TOMASZ SZMYD, D.P.M
Podiatrist in CHICAGO, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
TOMASZ SZMYD, D.P.M reported a CMS MIPS final score of 58.962/100 — below the 83.1 national average — and filed 795 Medicare Part D claims in 2023.
- 58.962/100
- MIPS score · -24 vs avg
- 795
- Part D claims, 2023
- 98%
- generic prescribing
- $512.91
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
TOMASZ SZMYD, D.P.M's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
59 5th percentile higher than 5% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about TOMASZ SZMYD, D.P.M?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Illinois
How Podiatrist compares to other specialties among Illinois providers
Podiatrist share within Illinois
Podiatrist is one of the more visible NUCC categories in Illinois
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
TOMASZ SZMYD, D.P.M's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 58.962/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Podiatrist) — 58.962/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Podiatrist US NPIs
58.962/100 MIPS final score — 24.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Podiatrist. Quality dim: 67.9497. Cost dim: 45.257.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
TOMASZ SZMYD, D.P.M appears in the CMS NPPES registry as a Podiatrist provider holding D.P.M credentials at 5501 W BELMONT AVE, CHICAGO, IL, 60641, with a listed phone of (773) 934-5503. NPI 1255370284 was issued on 06/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SZMYD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 795 prescription claims written by this provider, covering 286 Medicare beneficiaries and totaling roughly $25K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 27.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 58.962/100 for the 2023 performance year (Quality 67.9497, Cost 45.257), compared with the national average of 83.1.
Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1255370284 |
|---|---|
| Specialty | Podiatrist |
| Credentials | D.P.M |
| Gender | Male |
| NPI Issued | 06/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm TOMASZ SZMYD, D.P.M's current license status, disciplinary history, and board certifications with the Illinois Department of Financial and Professional Regulation in Illinois before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TOMASZ SZMYD, D.P.M. Source: openpaymentsdata.cms.gov.
Total received
$513
Largest payer
Stryker Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Illinois IDFPR 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to TOMASZ SZMYD, D.P.M. To verify TOMASZ SZMYD, D.P.M's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 795 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 895
- Total Day Supply
- 20,324
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $8K
- Generic Drug Cost
- $17K
- Opioid Claims
- 219 (27.5% rate)
- Antibiotic Claims
- 60
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 1.78
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 51, 65-74: 138, 75-84: 70, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What TOMASZ SZMYD, D.P.M prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
136 claims
- Gabapentin
Gabapentin
128 claims
- Ammonium Lactate 51
Ammonium Lactate
51 claims
- Tramadol Hcl 51
Tramadol Hcl
51 claims
- Ciclopirox 44
Ciclopirox
44 claims
- Ketoconazole 42
Ketoconazole
42 claims
- Meloxicam 36
Meloxicam
36 claims
- Triamcinolone Acet… 35
Triamcinolone Acetonide
35 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 136 |
| Gabapentin | 128 |
| Ammonium Lactate | 51 |
| Tramadol Hcl | 51 |
| Ciclopirox | 44 |
| Ketoconazole | 42 |
| Meloxicam | 36 |
| Triamcinolone Acetonide | 35 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 31 |
| Methylprednisolone | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How TOMASZ SZMYD, D.P.M fits within the Podiatrist landscape nationally.
TOMASZ SZMYD, D.P.M's 795 claims are above the specialty average of 304.
Nearby Podiatrist Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as SZMYD.
Compare Podiatrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Illinois
Frequently Asked Questions
What is TOMASZ SZMYD, D.P.M's specialty? ▼
How much does TOMASZ SZMYD, D.P.M prescribe under Medicare Part D? ▼
What is TOMASZ SZMYD, D.P.M's Medicare quality score? ▼
Where is TOMASZ SZMYD, D.P.M located? ▼
What is TOMASZ SZMYD, D.P.M's NPI number? ▼
Does TOMASZ SZMYD, D.P.M prescribe more brand-name or generic drugs? ▼
Does TOMASZ SZMYD, D.P.M prescribe opioids? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does TOMASZ SZMYD, D.P.M prescribe most often? ▼
Does TOMASZ SZMYD, D.P.M accept Medicare? ▼
How can I verify TOMASZ SZMYD, D.P.M's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology